p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism

Abstract The p53 tumor suppressor regulates multiple context-dependent tumor suppressive programs. Although p53 is mutated in ~90% of small cell lung cancer (SCLC) tumors, how p53 mediates tumor suppression in this context is unknown. Here, using a mouse model of SCLC in which endogenous p53 express...

Full description

Bibliographic Details
Main Authors: Jonuelle Acosta, Qinglan Li, Nelson F. Freeburg, Nivitha Murali, Alexandra Indeglia, Grant P. Grothusen, Michelle Cicchini, Hung Mai, Amy C. Gladstein, Keren M. Adler, Katherine R. Doerig, Jinyang Li, Miguel Ruiz-Torres, Kimberly L. Manning, Ben Z. Stanger, Luca Busino, Maureen Murphy, Liling Wan, David M. Feldser
Format: Article
Language:English
Published: Nature Portfolio 2023-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-023-40161-9
_version_ 1827895074455814144
author Jonuelle Acosta
Qinglan Li
Nelson F. Freeburg
Nivitha Murali
Alexandra Indeglia
Grant P. Grothusen
Michelle Cicchini
Hung Mai
Amy C. Gladstein
Keren M. Adler
Katherine R. Doerig
Jinyang Li
Miguel Ruiz-Torres
Kimberly L. Manning
Ben Z. Stanger
Luca Busino
Maureen Murphy
Liling Wan
David M. Feldser
author_facet Jonuelle Acosta
Qinglan Li
Nelson F. Freeburg
Nivitha Murali
Alexandra Indeglia
Grant P. Grothusen
Michelle Cicchini
Hung Mai
Amy C. Gladstein
Keren M. Adler
Katherine R. Doerig
Jinyang Li
Miguel Ruiz-Torres
Kimberly L. Manning
Ben Z. Stanger
Luca Busino
Maureen Murphy
Liling Wan
David M. Feldser
author_sort Jonuelle Acosta
collection DOAJ
description Abstract The p53 tumor suppressor regulates multiple context-dependent tumor suppressive programs. Although p53 is mutated in ~90% of small cell lung cancer (SCLC) tumors, how p53 mediates tumor suppression in this context is unknown. Here, using a mouse model of SCLC in which endogenous p53 expression can be conditionally and temporally regulated, we show that SCLC tumors maintain a requirement for p53 inactivation. However, we identify tumor subtype heterogeneity between SCLC tumors such that p53 reactivation induces senescence in a subset of tumors, while in others, p53 induces necrosis. We pinpoint cyclophilins as critical determinants of a p53-induced transcriptional program that is specific to SCLC tumors and cell lines poised to undergo p53-mediated necrosis. Importantly, inhibition of cyclophilin isomerase activity, or genetic ablation of specific cyclophilin genes, suppresses p53-mediated necrosis by limiting p53 transcriptional output without impacting p53 chromatin binding. Our study demonstrates that intertumoral heterogeneity in SCLC influences the biological response to p53 restoration, describes a cyclophilin-dependent mechanism of p53-regulated cell death, and uncovers putative mechanisms for the treatment of this most-recalcitrant tumor type.
first_indexed 2024-03-12T22:16:28Z
format Article
id doaj.art-ff845a6444d4462dbb8f4fdf61c394b3
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-03-12T22:16:28Z
publishDate 2023-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-ff845a6444d4462dbb8f4fdf61c394b32023-07-23T11:18:34ZengNature PortfolioNature Communications2041-17232023-07-0114111810.1038/s41467-023-40161-9p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanismJonuelle Acosta0Qinglan Li1Nelson F. Freeburg2Nivitha Murali3Alexandra Indeglia4Grant P. Grothusen5Michelle Cicchini6Hung Mai7Amy C. Gladstein8Keren M. Adler9Katherine R. Doerig10Jinyang Li11Miguel Ruiz-Torres12Kimberly L. Manning13Ben Z. Stanger14Luca Busino15Maureen Murphy16Liling Wan17David M. Feldser18Department of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaBiochemistry and Molecular Biophysics Graduate Group, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaCell and Molecular Biology Graduate Group, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaCell and Molecular Biology Graduate Group, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaDepartment of Cancer Biology, Perelman School of Medicine, University of PennsylvaniaAbstract The p53 tumor suppressor regulates multiple context-dependent tumor suppressive programs. Although p53 is mutated in ~90% of small cell lung cancer (SCLC) tumors, how p53 mediates tumor suppression in this context is unknown. Here, using a mouse model of SCLC in which endogenous p53 expression can be conditionally and temporally regulated, we show that SCLC tumors maintain a requirement for p53 inactivation. However, we identify tumor subtype heterogeneity between SCLC tumors such that p53 reactivation induces senescence in a subset of tumors, while in others, p53 induces necrosis. We pinpoint cyclophilins as critical determinants of a p53-induced transcriptional program that is specific to SCLC tumors and cell lines poised to undergo p53-mediated necrosis. Importantly, inhibition of cyclophilin isomerase activity, or genetic ablation of specific cyclophilin genes, suppresses p53-mediated necrosis by limiting p53 transcriptional output without impacting p53 chromatin binding. Our study demonstrates that intertumoral heterogeneity in SCLC influences the biological response to p53 restoration, describes a cyclophilin-dependent mechanism of p53-regulated cell death, and uncovers putative mechanisms for the treatment of this most-recalcitrant tumor type.https://doi.org/10.1038/s41467-023-40161-9
spellingShingle Jonuelle Acosta
Qinglan Li
Nelson F. Freeburg
Nivitha Murali
Alexandra Indeglia
Grant P. Grothusen
Michelle Cicchini
Hung Mai
Amy C. Gladstein
Keren M. Adler
Katherine R. Doerig
Jinyang Li
Miguel Ruiz-Torres
Kimberly L. Manning
Ben Z. Stanger
Luca Busino
Maureen Murphy
Liling Wan
David M. Feldser
p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
Nature Communications
title p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
title_full p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
title_fullStr p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
title_full_unstemmed p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
title_short p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism
title_sort p53 restoration in small cell lung cancer identifies a latent cyclophilin dependent necrosis mechanism
url https://doi.org/10.1038/s41467-023-40161-9
work_keys_str_mv AT jonuelleacosta p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT qinglanli p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT nelsonffreeburg p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT nivithamurali p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT alexandraindeglia p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT grantpgrothusen p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT michellecicchini p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT hungmai p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT amycgladstein p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT kerenmadler p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT katherinerdoerig p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT jinyangli p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT miguelruiztorres p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT kimberlylmanning p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT benzstanger p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT lucabusino p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT maureenmurphy p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT lilingwan p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism
AT davidmfeldser p53restorationinsmallcelllungcanceridentifiesalatentcyclophilindependentnecrosismechanism